SCHEMBL4970927

SCHEMBL4970927

Fc1ccccc1C1CCC[N]C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
KDM1A O60341 4/20 0.39
KDM1B Q8NB78 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
NOS3 P29474 2/20 0.37
NOS2 P35228 2/20 0.37
NOS1 P29475 1/20 0.37
PROKR1 Q8TCW9 1/20 0.36
MAOB P27338 2/20 0.36
MAOA P21397 1/20 0.36
HCAR2 Q8TDS4 2/20 0.35
GRM2 Q14416 2/20 0.35
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4970930 1.00 KDM4E (0.41) KDM4EGAAKDM1AKDM1BADRA1D
SCHEMBL4973228 1.00 KDM4E (0.41) KDM4EGAAKDM1AKDM1BADRA1D
SCHEMBL7289895 0.89 KDM1A (0.41) KDM4EGAAKDM1AKDM1BADRA1D
SCHEMBL9820873 0.79 BRD4 (0.38) KDM1AHTR2CHTR2BNPC1ALDH1A1
SCHEMBL316350 0.78 KDM4E (0.55) KDM4EGAAKDM1AKDM1BADRA1D
SCHEMBL434672 0.78 KDM4E (0.50) KDM4EGAAKDM1AKDM1BADRA1D
SCHEMBL3118740 0.77 KDM1A (0.44) KDM4EGAAKDM1AKDM1BADRA1D
SCHEMBL128052 0.77 KDM4E (0.53) KDM4EGAAKDM1AKDM1BADRA1D
SCHEMBL29436912 0.77 KDM4E (0.53) KDM4EGAAKDM1AKDM1BADRA1D
Ammonia Solution, Strong SCHEMBL17982788 0.77 KDM4E (0.48) KDM4EGAAKDM1AKDM1BADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070265270-A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2007-11-15 US claimed
EP-1991540-A1 CINNOLINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS Amgen Inc. (US) 2008-11-19 EP disclosed
US-20070265270-A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2007-11-15 US disclosed
WO-2007098214-A1 CINNOLINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC. (US) 2007-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265270-A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors PDE7A, PDE10A, PDE7B KDM4E 2365/4885GAA 122/4885KDM1A 1587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.